Published in Mol Cell Biol on September 26, 2016
Oncolytic Viruses-Natural and Genetically Engineered Cancer Immunotherapies. Front Oncol (2017) 0.75
Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J Cell Biol (2001) 13.98
Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell (2006) 13.15
A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature (2008) 10.84
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ (2008) 10.45
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012. Cell Death Differ (2011) 9.44
Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct (1998) 9.18
Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol (2000) 8.49
Identification of a molecular signaling network that regulates a cellular necrotic cell death pathway. Cell (2008) 7.61
Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem (2005) 4.56
The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell (2012) 4.37
Overview of cell death signaling pathways. Cancer Biol Ther (2005) 4.22
IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy. J Clin Invest (2005) 4.07
A role for tumor necrosis factor receptor-2 and receptor-interacting protein in programmed necrosis and antiviral responses. J Biol Chem (2003) 3.70
Necroptosis as an alternative form of programmed cell death. Curr Opin Cell Biol (2010) 3.51
Compartmentalization of TNF receptor 1 signaling: internalized TNF receptosomes as death signaling vesicles. Immunity (2004) 3.26
Necroptosis: the release of damage-associated molecular patterns and its physiological relevance. Immunity (2013) 3.22
Necrosis, a well-orchestrated form of cell demise: signalling cascades, important mediators and concomitant immune response. Biochim Biophys Acta (2006) 3.12
Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev (2003) 2.84
FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci U S A (2008) 2.52
Mechanisms of necroptosis in T cells. J Exp Med (2011) 2.51
Phosphorylation of RelA/p65 on serine 536 defines an I{kappa}B{alpha}-independent NF-{kappa}B pathway. J Biol Chem (2005) 2.30
Antigen-mediated T cell expansion regulated by parallel pathways of death. Proc Natl Acad Sci U S A (2008) 2.20
Tumor necrosis factor-alpha-induced IKK phosphorylation of NF-kappaB p65 on serine 536 is mediated through the TRAF2, TRAF5, and TAK1 signaling pathway. J Biol Chem (2003) 2.20
Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol Cell Biol (2004) 2.15
Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J Exp Med (1998) 2.11
Diverse autophagosome membrane sources coalesce in recycling endosomes. Cell (2013) 2.07
Posttranslational modifications of NF-kappaB: another layer of regulation for NF-kappaB signaling pathway. Cell Signal (2010) 1.99
Mitochondrial reactive oxygen species activation of p38 mitogen-activated protein kinase is required for hypoxia signaling. Mol Cell Biol (2005) 1.97
Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity. Cell Death Differ (2003) 1.91
Shikonin circumvents cancer drug resistance by induction of a necroptotic death. Mol Cancer Ther (2007) 1.90
Getting TRAIL back on track for cancer therapy. Cell Death Differ (2014) 1.86
PGAM5, a Bcl-XL-interacting protein, is a novel substrate for the redox-regulated Keap1-dependent ubiquitin ligase complex. J Biol Chem (2006) 1.78
TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation. Cell Death Differ (2012) 1.72
Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis. Oncogene (2000) 1.69
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol Med (2012) 1.68
Function, structure and regulation of the vacuolar (H+)-ATPases. Arch Biochem Biophys (2008) 1.68
Fas-associated death domain (FADD) is a negative regulator of T-cell receptor-mediated necroptosis. Proc Natl Acad Sci U S A (2010) 1.67
P38 alpha mitogen-activated protein kinase sensitizes cells to apoptosis induced by different stimuli. Mol Biol Cell (2003) 1.65
Bcl-2 Phosphorylation by p38 MAPK: identification of target sites and biologic consequences. J Biol Chem (2006) 1.60
PARP-1 is involved in autophagy induced by DNA damage. Autophagy (2009) 1.50
TRAIL on trial: preclinical advances in cancer therapy. Trends Mol Med (2013) 1.49
FTY720 inhibits ceramide synthases and up-regulates dihydrosphingosine 1-phosphate formation in human lung endothelial cells. J Biol Chem (2009) 1.46
Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes. Cell Death Differ (2013) 1.42
Necroptosis in health and diseases. Semin Cell Dev Biol (2014) 1.42
Ceramide mediates caspase-independent programmed cell death. FASEB J (2005) 1.36
Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis. Cell Death Differ (2014) 1.29
Requirement of FADD, NEMO, and BAX/BAK for aberrant mitochondrial function in tumor necrosis factor alpha-induced necrosis. Mol Cell Biol (2011) 1.24
Regulation of programmed cell death by NF-kappaB and its role in tumorigenesis and therapy. Adv Exp Med Biol (2008) 1.24
Multiple death pathways in TNF-treated fibroblasts: RIP3- and RIP1-dependent and independent routes. Cell Res (2011) 1.20
TNF-induced necroptosis and PARP-1-mediated necrosis represent distinct routes to programmed necrotic cell death. Cell Mol Life Sci (2013) 1.20
Evading apoptosis in cancer. Trends Cell Biol (2013) 1.17
Pitstop 2 is a potent inhibitor of clathrin-independent endocytosis. PLoS One (2012) 1.16
Eukaryotic protein synthesis inhibitors identified by comparison of cytotoxicity profiles. RNA (2004) 1.15
Regulation of synaptic structure by ubiquitin C-terminal hydrolase L1. J Neurosci (2009) 1.13
Staurosporine induces necroptotic cell death under caspase-compromised conditions in U937 cells. PLoS One (2012) 1.11
Necroptosis: is there a role for mitochondria? Front Physiol (2014) 1.08
Restricted mitochondrial protein acetylation initiates mitochondrial autophagy. J Cell Sci (2013) 1.07
Phosphorylation of Atg5 by the Gadd45β-MEKK4-p38 pathway inhibits autophagy. Cell Death Differ (2012) 1.01
RIP1 mediates the protection of geldanamycin on neuronal injury induced by oxygen-glucose deprivation combined with zVAD in primary cortical neurons. J Neurochem (2011) 0.99
p38alpha MAPK is required for contact inhibition. Oncogene (2005) 0.96
Autocrine stimulation of human pancreatic duct-like development by soluble isoforms of epimorphin in vitro. J Cell Biol (2001) 0.96
Doxorubicin enhances TRAIL-induced cell death via ceramide-enriched membrane platforms. Apoptosis (2007) 0.93
Intramitochondrial serine protease activity of Omi/HtrA2 is required for caspase-independent cell death of human neutrophils. Cell Death Differ (2004) 0.92
The murine TRAIL receptor signals caspase-independent cell death through ceramide. Exp Cell Res (2006) 0.90
Sorafenib-induced defective autophagy promotes cell death by necroptosis. Oncotarget (2015) 0.89
Onto better TRAILs for cancer treatment. Cell Death Differ (2016) 0.88
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis. Cell Death Dis (2014) 0.86
TNFα-induced necroptosis and autophagy via supression of the p38-NF-κB survival pathway in L929 cells. J Pharmacol Sci (2011) 0.86
Small molecule inhibitors of acid sphingomyelinase. Cell Physiol Biochem (2010) 0.85
The proteases HtrA2/Omi and UCH-L1 regulate TNF-induced necroptosis. Cell Commun Signal (2013) 0.85
Cytokines from the tumor microenvironment modulate sirtinol cytotoxicity in A549 lung carcinoma cells. Cytokine (2013) 0.85
Cathepsin B-independent abrogation of cell death by CA-074-OMe upstream of lysosomal breakdown. Cell Death Differ (2004) 0.84
TRAIL-induced programmed necrosis as a novel approach to eliminate tumor cells. BMC Cancer (2014) 0.84
Learning from nature: advances in geldanamycin- and radicicol-based inhibitors of Hsp90. J Org Chem (2013) 0.84
Principles of antibody-mediated TNF receptor activation. Cell Death Differ (2015) 0.84
Cathepsin inhibition-induced lysosomal dysfunction enhances pancreatic beta-cell apoptosis in high glucose. PLoS One (2015) 0.83
Melatonin attenuates carbon tetrachloride-induced liver fibrosis via inhibition of necroptosis. Transl Res (2015) 0.82
CA-074Me, a cathepsin B inhibitor, decreases APP accumulation and protects primary rat cortical neurons treated with okadaic acid. Neurosci Lett (2013) 0.82
Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis. Cell Commun Signal (2015) 0.82
Mouse embryonic stem cells undergo charontosis, a novel programmed cell death pathway dependent upon cathepsins, p53, and EndoG, in response to etoposide treatment. Stem Cell Res (2013) 0.81
The Roles of ROS and Caspases in TRAIL-Induced Apoptosis and Necroptosis in Human Pancreatic Cancer Cells. PLoS One (2015) 0.81
Hydrogen inhalation is neuroprotective and improves functional outcomes in mice after intracerebral hemorrhage. Acta Neurochir Suppl (2011) 0.80
NF-kappaB as a determinant of distinct cell death pathways. Methods Enzymol (2008) 0.78
Potent inhibition of acid sphingomyelinase by phosphoinositide analogues. Chembiochem (2009) 0.78
Necroptosis mediates TNF-induced toxicity of hippocampal neurons. Biomed Res Int (2014) 0.78
Cancer and necroptosis: friend or foe? Cell Mol Life Sci (2016) 0.75